XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Business Segment Reporting
3 Months Ended
Aug. 26, 2018
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
9
.
Business Segment Reporting
 
Prior to
May 2018,
the Company managed its business operations through
three
strategic reportable business segments: Packaged Fresh Vegetables, Food Export, and Biomaterials. These segments were based upon the information reported to the Chief Executive Officer, who is the chief operating decision maker ("CODM"). However, in
May 2018,
the Company discontinued its Food Export business segment. As a result, the Company met the requirements of ASC
205
-
20
and ASC
360
to report the results of the Food Export business segment as discontinued operations. The operating results for the Food Export business segment, for the
three
months ended
August 27, 2017,
have been reclassified to discontinued operations and are
no
longer reported as a separate segment.
  
Beginning in fiscal year
2019,
the Company now has
three
strategic reportable business segments: the Natural Foods segment, the Biomaterials segment, and the Other segment. Our Natural Foods business is comprised of our historical Packaged Fresh Vegetables and BreatheWay® activities, our
O
olive oils and wine vinegars business and our new Now Planting
®
refrigerated soups business. Our Natural Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry and are sold under the Eat Smart
®
and GreenLine
®
brands. The Natural Foods segment also includes sales of BreatheWay packaging to partners for fruit and vegetable products, sales of olive oils and wine vinegars under our
O
brand and sales of soups under our Now Planting brand. The Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Other segment includes corporate general and administrative expenses, non-Natural Foods and non-Biomaterials interest income and income tax expenses. All of the assets of the Company are located within the United States of America.
  
The Company’s international sales by geography are based on the billing address of the customer and were as follows (in millions): 
 
   
Three Months Ended
 
   
August 26, 2018
   
August 27, 2017
 
Canada
  $
19.9
    $
18.0
 
Belgium
  $
2.0
    $
2.2
 
Ireland
  $
1.1
    $
0.8
 
Denmark
  $
0.2
    $
0.1
 
Switzerland
  $
0.1
    $
 
Mexico
  $
0.1
    $
0.1
 
All Other Countries
  $
0.4
    $
0.5
 
 
Operations by business segment consisted of the following (in thousands):
 
Three Months Ended August 26, 2018
 
Natural Foods
   
Biomaterials
   
Other
   
Total
 
Net sales
  $
112,051
    $
12,617
    $
    $
124,668
 
International sales
  $
20,112
    $
3,716
    $
    $
23,828
 
Gross profit
  $
13,370
    $
2,967
    $
    $
16,337
 
Net income (loss) from continuing operations
  $
1,768
    $
(547
)
  $
(1,031
)
  $
190
 
Depreciation and amortization
  $
2,095
    $
976
    $
74
    $
3,145
 
Dividend income
  $
413
    $
    $
    $
413
 
Interest income
  $
31
    $
    $
15
    $
46
 
Interest expense, net
(1)
  $
587
    $
    $
171
    $
758
 
Income tax expense (benefit)
  $
663
    $
(182
)
  $
(417
)
  $
64
 
                                 
Three Months Ended August 27, 2017
                               
Net sales
  $
103,617
    $
12,164
    $
    $
115,781
 
International sales
  $
18,174
    $
3,499
    $
    $
21,673
 
Gross profit
  $
15,280
    $
3,522
    $
    $
18,802
 
Net income (loss) from continuing operations
  $
3,821
    $
(155
)
  $
(1,311
)
  $
2,355
 
Depreciation and amortization
  $
2,052
    $
865
    $
37
    $
2,954
 
Dividend income
  $
413
    $
    $
    $
413
 
Interest income
  $
11
    $
    $
20
    $
31
 
Interest expense, net
  $
    $
    $
404
    $
404
 
Income tax expense (benefit)
  $
1,096
    $
(27
)   $
241
    $
1,310
 
 
(
1
)
Beginning in
first
quarter of fiscal
2019,
the Company began allocating interest expense to its reportable segments in information provided to its CODM to enhance visibility into how financing activities impact the discrete financial results.
 
During the
three
months ended
August 26, 2018
and
August 27, 2017,
sales to the Company’s top
five
customers accounted for
48%
and
47%
of sales, respectively. The Company’s top
two
customers, Costco Wholesale Corporation and Wal-Mart Stores, Inc., from the Natural Foods segment, accounted for
19%
and
18%,
respectively, of revenues for the
three
months ended
August 26, 2018,
and
18%
for both for the
three
months ended
August 27, 2017.
The Company expects that, for the foreseeable future, a limited number of customers
may
continue to account for a significant portion of its revenues.